Evidence map›Paper›PMID 30733336›Full record

ArticleThe Journal of biological chemistry2019

The

Colleen M Pike, Rebecca Boyer-Andersen, Lisa N Kinch, Jeffrey L Caplan, M Ramona Neunuebel

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Systematic Discovery of Novel Phosphoinositide-Binding Effectors inbioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Evolution and Adaptation ofBiomolecules · 2021
    Review
  14. Review
  15. Article
  16. Review
  17. Phosphoinositides and the Fate ofFrontiers in immunology · 2020
    Review
  18. Review
  19. Article
  20. Legionella dismantles linear ubiquitin.Nature microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Colleen M PikeFrom the Delaware Biotechnology Institute and.
Rebecca Boyer-AndersenFrom the Delaware Biotechnology Institute and.
Lisa N Kinchthe Howard Hughes Medical Institute, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390.
Jeffrey L CaplanFrom the Delaware Biotechnology Institute and.
M Ramona NeunuebelFrom the Delaware Biotechnology Institute and neunr@udel.edu.

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI MELINDA K DUNCAN · 2012 to 2026
$67.2M
This renovation project will create over 1455 sq. ft. of state- of-the-art reseaP20GM104316 · NIGMS · UNIVERSITY OF DELAWARE · PI SCHMITZ, KARL ROBERT · 2014 to 2024
$26.8M
Characterization of Legionella effectors targeting host membrane compartmentsR21AI142317 · NIAID · UNIVERSITY OF DELAWARE · PI NEUNUEBEL, MARIA RAMONA · 2019 to 2020
$415k
NIAID NIH HHS R21 AI142317NIGMS NIH HHS P20 GM103446NIGMS NIH HHS P20 GM104316
6 · The paper itself

Abstract

Upon phagocytosis into macrophages, the intracellular bacterial pathogen

Indexed as

Bacterial ProteinsEndosomesHEK293 CellsHeLa CellsHumansLegionella pneumophilaLegionnaires' DiseaseLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsLysosomesMacrophagesPhosphatidylinositol 3-KinasesPhosphatidylinositol Phosphatesrab5 GTP-Binding ProteinsU937 CellsVacuolesBacterial ProteinsLAMP1 protein, humanLysosomal-Associated Membrane Protein 1Lysosomal Membrane ProteinsPhosphatidylinositol 3-Kinasesphosphatidylinositol 3-phosphatePhosphatidylinositol PhosphatesRAB5C protein, humanrab5 GTP-Binding ProteinsWortmanninbacterial effectorsbacterial pathogenesiscellular localizationhost–pathogen interactionimmune evasioninfectionLegionella pneumophilaLegionnaires' diseasephosphoinositidevirulence factor

Identifiers

PMID30733336
PMCPMC6484141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.